Skip to content
Lower risk Drug recall · FDA · Published January 12, 2023

Nephron Sc 0.9% Sodium Chloride Injection Recall: Potential Product Carryover Risk

Nephron Sc recalls 100mL 0.9% Sodium Chloride Injection due to potential trace product carryover from manufacturing. This is a drug product for medical use only.

🇺🇸 FDA recall #D-0177-2023DrugNephron Sc ›
Take action

Contact the company

Recalling firmNephron Sc Inc4500 12th Street Ext · West Columbia, SC 29172-3025
✎ GovInfoNow plain-language explainer

Neph: Nephron Sc has recalled 100mL 0.9% Sodium Chloride Injection (medical saline) because of potential trace amounts of product carryover during manufacturing. This could affect safety if used improperly. Read more at govinfonow.com/recall/34006-nephron-sc-0-9-sodium-chloride-injection-recall-potential-product.

Source Summary by GovInfoNow · govinfonow.com/recall/34006-nephron-sc-0-9-sodium-chloride-injection-recall-potential-product · Updated August 18, 2026 · FDA enforcement record: FDA #D-0177-2023

Cite this page

“Nephron Sc 0.9% Sodium Chloride Injection Recall: Potential Product Carryover Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34006-nephron-sc-0-9-sodium-chloride-injection-recall-potential-product. Based on FDA recall #D-0177-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0177-2023%22&limit=1).

Nephron Sc Inc voluntarily recalled 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bags due to potential product carryover from CGMP deviations, the FDA said on Jan. 12, 2023.

How to tell if you have it

  • Brand: Nephron Sc
  • Product: 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation
  • NDC: 0487-4301-10
  • UPC: 3 04874 30110 3
  • Lot: 271043
  • Expiration: 03/2023
  • Quantity: 378 bags

The hazard

The recall addresses CGMP deviations that pose a potential for trace amounts of product carryover.

Context

GovInfoNow's records show Nephron Sc Inc has issued three other recalls since Aug. 10, 2022, including a Feb. 23, 2023 recall for Sterile Water for Injection due to potential product carryover and a Jan. 13, 2023 recall for Racepinephrine Inhaler due to short fill hazards. Other recent recalls of similar products include B. Braun Medical's Aug. 19, 2026 sodium chloride injection recall for particulate matter hazard, Fresenius Kabi's March 11, 2026 recall for lack of sterility assurance, and Baxter's Aug. 17, 2026 recall for fiberglass particulates risk.

How to tell if you have this one

Check for the NDC code 0487-4301-10 on the container. The product was sold with lot number 271043 and expires March 2023.

  • Brand
    Nephron Sc
  • Product
    0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lotsQuantityNDC
D-0177-20230.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.; Lot: 271043, Exp. 03/2023378 bags0487-4301-25, 0487-4301-10, 0487-4301-05, 0487-4301-50
D-0178-2023Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 30 x 5 mL Single-Dose Vials per carton, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th Street Extension, W. Columbia, SC 29172, NDC 0487-6105-01, UPC 3 04876 10501 3.; Lots: 124081, 124082, Exp. 04/2023; 224031, Exp. 01/2024389,730 vials0487-6105-01
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC code 0487-4301-10 and lot number 271043 on the container.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jan 12, 202312. FDA classified it Class II: Jan 24, 202323. Published in FDA’s Enforcement Report: Feb 1, 202334. FDA terminated the recall: Oct 11, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to potential trace product carryover during manufacturing, but the product is still considered safe for medical use under normal conditions.

What should I do if I have this product?

The recall does not require immediate action; check the product details and contact Nephron Sc if you have concerns.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0177-2023 (January 12, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0177-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA